Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics

Annals of Allergy, Asthma and Immunology

Volumn 85, Issue 6 I, 2000, Pages 477-482

  Stevenson, D D ^a   Simon, R A ^a   Mathison, D A ^a   Christiansen, S C ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LEUKOTRIENE; MONTELUKAST;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME;

EID: 0034506454     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62575-6     Document Type: Article

References (23)

1. Aspirin-sensitive rhinosinusitis/asthma: Spectrum of adverse reactions to aspirin
2. Aspirin tolerance in asthma-detection by challenge
3. Oral challenges to detect aspirin and sensitivity in asthma
4. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation
5. The role and contribution of leukotrienes in asthma
6. Treatment of asthma with drugs modifying the leukotriene pathway
7. Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy
8. The role of leukotriene modifiers in the treatment of asthma
9. Antileukotrienes in the treatment of asthma
10. Leukotriene inhibitors and antagonists in asthma
11. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
12. SE. Effect of the leukotriene receptor antagonist MK-0679 on line pulmonary function in aspirin sensitive asthmatic subjects
13. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects
14. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics
15. The potent and selective sulfidopeptide leukotriene antagonist SK&F 104353, inhibits aspirin-induced asthma
16. Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078
17. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma
18. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin
19. The leukotriene receptor antagonist MK-0679 blocks airway obstruction induced by bronchial provocation with lysine-aspirin in aspirin-sensitive asthmatics
20. Aspirin desensitization in aspirin sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period
21. Lack of effect of the 5-lipoxygenase inhibitor zileuton in blocking oral aspirin challenges in aspirin sensitive asthmatics
22. Release of leukotrienes, prostaglandins and histamine into nasal secretions of aspirin-sensitive asthmatic during reaction to aspirin